Results 11 to 20 of about 121,794,009 (205)

Histopathological changes of the buccal mucosa and skin after botulinum neurotoxin intramuscular injection in rats (immunohistochemical study)

BMC Oral Health
Background A surplus of clinical studies focused mainly on the clinical impacts of botulinum neurotoxin type A disregarding the histopathological changes stemming from its injection.
Gihan S. Hassan, Basant H. Abouzaid, Reda G. Saleh   +2 more
doaj   +2 more sources

Neutralizing antibodies to botulinum neurotoxin type A in aesthetic medicine: five case reports

Clinical, Cosmetic and Investigational Dermatology, 2013
Sebastian Torres,1 Mark Hamilton,2 Elena Sanches,4 Polina Starovatova,3 Elena Gubanova,3 Tatiana Reshetnikova51Di Stefano Velona Clinic, Catania, Italy; 2Hamilton Face Clinic, Dublin, Ireland; 3Preventive Medicine Clinic "Vallex M", Moscow ...
Torres S, Hamilton M, Sanches E, Starovatova P, Gubanova E, Reshetnikova T   +5 more
doaj   +1 more source

Intraprostatic botulinum neurotoxin type a injection for benign prostatic hyperplasia: preliminary results with a newly purified neurotoxin. [PDF]

Acta medica Okayama, 2012
Several studies have demonstrated the efficacy of intraprostatic injection of botulinum neurotoxin type A (BoNT/A) against symptomatic benign prostatic hyperplasia (BPH). The most commonly used BoNT/A product, Botox(®), forms large complexes and composed of neurotoxin (NTX) as well as non-toxic components.
Yokoyama, Teruhiko, Yamamoto, Yumiko, Suzuki, Tomonori, Oguma, Keiji, Nagai, Atsushi   +4 more
openaire   +4 more sources

What a Patient With Refractory Idiopathic Detrusor Overactivity Should Know About Botulinum Neurotoxin Type A Injection

Journal of Urology, 2009
We documented the effects of intradetrusor injections of botulinum neurotoxin type A (Botox(R)) for refractory idiopathic detrusor overactivity so that prospective patients maybe properly informed about possible improvement in quality of life, the duration of interinjection intervals and the risk of clean intermittent self-catheterization.A total of 81
Khan, Shahid, Kessler, Thomas M, Apostolidis, Apostolos, Kalsi, Vinay, Panicker, Jalesh, Roosen, Alexander, Gonzales, Gwen, Haslam, Collete, Elneil, Sohier, Fowler, Clare J, Dasgupta, Prokar   +10 more
openaire   +5 more sources

Botulinum Neurotoxin A Injections in Spasmodic Entropion: A Clinical Retrospective Cohort Study

Toxins
While surgical procedure has been considered as the golden standard treatment for spasmodic entropion, Botulinum Neurotoxin A can be indicated in the treatment of spasmodic entropion for fragile elderly patients.
Brigitte Girard, Fabienne Carré, Simon Begnaud   +2 more
doaj   +2 more sources

Dysphagia After Cosmetic Submandibular Gland Botulinum Neurotoxin Type A Injection: A Case Report. [PDF]

Healthcare (Basel)
Background: Cosmetic injection of botulinum neurotoxin type A (BoNT/A) into the submandibular glands is increasingly performed to enhance jawline contour. Although generally considered safe, unintended diffusion of the toxin can impair pharyngeal musculature and lead to dysphagia.
Yang S, Yi YG.
europepmc   +3 more sources

Recombinant versus native botulinum neurotoxin type A: structural and pharmacodynamic comparison. [PDF]

Acta Crystallogr F Struct Biol Commun
For the first time, the recombinant core botulinum neurotoxin type A (BoNT/A) expressed in Escherichia coli and nicked in vitro is shown to be structurally identical to native BoNT/A from Clostridium botulinum, enabling direct activity comparison between the recombinant product and the native toxin.Botulinum neurotoxins (BoNTs) are highly potent ...
Yao Z, Xu L, Lu Y, Gong H, Sun X, Zhao Y, Chen J, Yang L, Chen Q, Yang W.   +9 more
europepmc   +2 more sources

Intraprostatic Botulinum Neurotoxin Type A Injection for Benign Prostatic Hyperplasia:Preliminary Results with a Newly Purified Neurotoxin

Intraprostatic Botulinum Neurotoxin Type A Injection for Benign Prostatic Hyperplasia:Preliminary Results with a Newly Purified Neurotoxin
Several studies have demonstrated the efficacy of intraprostatic injection of botulinum neurotoxin type A (BoNT/A) against symptomatic benign prostatic hyperplasia (BPH). The most commonly used BoNT/A product, Botox®, forms large complexes and composed of neurotoxin (NTX) as well as non-toxic components. We purified NTX lacking non-toxic components. We
Oguma, Keiji, Suzuki, Tomonori, Yamamoto, Yumiko, Nagai, Atsushi, Yokoyama, Teruhiko   +4 more
openaire   +2 more sources

Clinical outcomes of individualized botulinum neurotoxin type A injection techniques in patients with essential blepharospasm. [PDF]

Korean J Ophthalmol, 2015
To assess the clinical outcomes following botulinum neurotoxin type A (BoNT-A) treatment with an individualized injection technique based on the types of spasms and to compare the results of the individualized injection technique with those of the conventional injection technique in the same patients.From November 2011 to July 2013, 77 BoNT-A ...
Sung Y, Nam SM, Lew H.
europepmc   +4 more sources

Ultrasound-Guided Botulinum Neurotoxin Type A Injection for Correcting Asymmetrical Smiles [PDF]

Aesthetic Surgery Journal, 2018
While ultrasound-guided injections are safer and more effective than the typical (blind) injection methods, there has been no report of ultrasound-guided injection techniques being applied to patients for aesthetic treatment or to patients with an asymmetrical smile.
Hyung-Jin, Lee, Ji-Soo, Kim, Kwan-Hyun, Youn, Jungwook, Lee, Hee-Jin, Kim   +4 more
openaire   +3 more sources